PYRGF vs. FENC, IMMP, TKNO, NMRA, SCPH, SOPH, ELDN, EDIT, ESPR, and DSGN
Should you be buying PyroGenesis Canada stock or one of its competitors? The main competitors of PyroGenesis Canada include Adherex Technologies (FENC), Prima BioMed (IMMP), Alpha Teknova (TKNO), Neumora Therapeutics (NMRA), scPharmaceuticals (SCPH), SOPHiA GENETICS (SOPH), Eledon Pharmaceuticals (ELDN), Editas Medicine (EDIT), Esperion Therapeutics (ESPR), and Design Therapeutics (DSGN). These companies are all part of the "pharmaceutical products" industry.
PyroGenesis Canada vs. Its Competitors
PyroGenesis Canada (NASDAQ:PYRGF) and Adherex Technologies (NASDAQ:FENC) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation.
Adherex Technologies has a net margin of -45.52% compared to PyroGenesis Canada's net margin of -115.14%.
Adherex Technologies has higher revenue and earnings than PyroGenesis Canada. Adherex Technologies is trading at a lower price-to-earnings ratio than PyroGenesis Canada, indicating that it is currently the more affordable of the two stocks.
In the previous week, Adherex Technologies had 2 more articles in the media than PyroGenesis Canada. MarketBeat recorded 2 mentions for Adherex Technologies and 0 mentions for PyroGenesis Canada. Adherex Technologies' average media sentiment score of 1.67 beat PyroGenesis Canada's score of 0.00 indicating that Adherex Technologies is being referred to more favorably in the news media.
PyroGenesis Canada has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Adherex Technologies has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500.
0.0% of PyroGenesis Canada shares are held by institutional investors. Comparatively, 55.5% of Adherex Technologies shares are held by institutional investors. 47.7% of PyroGenesis Canada shares are held by company insiders. Comparatively, 11.8% of Adherex Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Adherex Technologies has a consensus target price of $13.00, indicating a potential upside of 49.08%. Given Adherex Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Adherex Technologies is more favorable than PyroGenesis Canada.
Summary
Adherex Technologies beats PyroGenesis Canada on 11 of the 16 factors compared between the two stocks.
Get PyroGenesis Canada News Delivered to You Automatically
Sign up to receive the latest news and ratings for PYRGF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PYRGF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PYRGF vs. The Competition
PyroGenesis Canada Competitors List
Related Companies and Tools
This page (NASDAQ:PYRGF) was last updated on 7/24/2025 by MarketBeat.com Staff
Free PYRGF Stock Alerts